CELLINK and Phasefocus announced a partnership to bring Livecyte, a high content live cell imager, to a wider market. Live cell imaging is essential to answering some of the most pressing questions in the life sciences, but conventional methods often involve labeling cells, a potentially harmful process that can alter research outcomes. Livecyte's integration of the patented label-free Quantitative Phase Imaging technology with state-of-the-art automatic cell tracking algorithms enables users to automatically characterize growth, morphology and motility of large populations of cells in a 96-well plate assay format. Combining CELLINK's already extensive product portfolio of bioprinters, liquid handlers and bioinks with Livecyte offers researchers a unique opportunity to improve workflow efficiencies in application areas such as drug discovery, regenerative medicine and cell-based assays.